The role of alpha blockers in children with dysfunctional voiding

Paul Austin1

  • 1Pediatric Urology, St. Louis Children's Hospital, Washington University School of Medicine, St. Louis, Missouri, USA. austinp@wustl.edu

Thescientificworldjournal
|September 8, 2009
PubMed

Insights

Alpha blocker therapy shows promise for improving bladder emptying in children with voiding disorders. This treatment appears safe and effective, though further research is needed for long-term validation.

Area of Science:

  • Pediatric Urology
  • Lower Urinary Tract Dysfunction
  • Pharmacology

Background:

  • Incomplete bladder emptying and dysfunctional voiding are common in children.
  • Alpha blockers are established treatments for adult voiding dysfunction.
  • Their use in pediatric populations is an emerging area.

Purpose of the Study:

  • To evaluate the efficacy and tolerability of alpha blocker therapy in pediatric patients.
  • To assess the impact of alpha blockers on bladder emptying in various pediatric voiding disorders.

Main Methods:

  • Review of existing literature and clinical data on alpha blocker use in children.
  • Analysis of treatment outcomes in pediatric patients with dysfunctional voiding.
  • Assessment of adverse events and long-term safety profiles.

Main Results:

  • Alpha blocker therapy appears well-tolerated in pediatric patients.
  • The therapy demonstrates efficacy in improving bladder emptying across different pediatric voiding disorders.
  • No significant short-term adverse effects were reported.

Conclusions:

  • Alpha blocker therapy is a potentially effective treatment for pediatric dysfunctional voiding.
  • Further long-term studies are necessary to fully validate its role and safety.
  • This therapeutic approach warrants continued investigation in pediatric urology.

Related Concept Videos

Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers01:22

Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers

α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
The Micturition Reflex01:26

The Micturition Reflex

Urination, or micturition involves the coordination of the bladder's detrusor muscle and two sphincters to ensure controlled bladder emptying.
The process begins with bladder filling, where the bladder wall stretches as urine accumulates. This stretching activates the urine storage reflex, mediated by the sacral spinal segments and the pontine storage center. Efferent sympathetic impulses stimulate the detrusor muscle to relax and the internal urethral sphincter to contract, facilitating urine...
Urodynamic Studies: Uroflowmetry01:19

Urodynamic Studies: Uroflowmetry

Uroflowmetry is a non-invasive urodynamic test designed to measure various aspects of urination, including volume, flow rate, and the time to void. This test is crucial for diagnosing and assessing conditions such as bladder outlet obstruction, bladder dysfunction, incomplete bladder emptying, incontinence, and urinary tract blockages caused by benign prostatic hyperplasia (BPH) and urethral strictures.Pre-Test Instructions:Before a uroflowmetry test, patients are typically advised to drink...
Imaging Studies VI: Voiding Cystourethrography and Cystography01:22

Imaging Studies VI: Voiding Cystourethrography and Cystography

Voiding Cystourethrography (VCUG) and Cystography are specialized radiographic procedures used to examine the structure and function of the bladder and urethra.Voiding Cystourethrography (VCUG)A Voiding Cystourethrogram (VCUG) is a diagnostic imaging procedure that assesses the anatomy and function of the lower urinary tract. It focuses on the bladder, bladder neck, and urethra, helping detect abnormalities such as vesicoureteral reflux (VUR)—the backward or reverse flow of urine into the...
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers01:27

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in bronchial smooth...
Anatomy of the Genitourinary System II: Bladder and Urethra01:19

Anatomy of the Genitourinary System II: Bladder and Urethra

The lower urinary system consists of the urinary bladder and urethra, which are essential in storing and expelling urine from the body. Together with the internal and external sphincters, these structures work together to regulate urination effectively.Anatomy of the BladderThe urinary bladder is a muscular, stretchable organ behind the pubic bone and in front of the rectum. In females, the bladder is positioned anterior to the vagina and inferior to the uterus, while in males, it is located...